--2025/Q1-- / 0.000--
--2024/Q4-- / 0.000--
--2024/Q30.000 / 0.000--
--2024/Q20.000 / 0.000--
--2024/Q10.000 / 2.333M--
Toll Brothers
TOL
Meritage Homes
MTH
Taylor Morrison Home
TMHC
D.R. Horton
DHI
KB Home
KBH
US Stock MarketDetailed Quotes
IKNA Ikena Oncology
- 1.600
- -0.010-0.62%
Close Jan 8 16:00 ET
77.21MMarket Cap-1.30P/E (TTM)
1.610High1.530Low196.03KVolume1.610Open1.610Pre Close310.21KTurnover1.91%Turnover RatioLossP/E (Static)48.26MShares1.94052wk High0.58P/B16.45MFloat Cap1.22052wk Low--Dividend TTM10.28MShs Float37.610Historical High--Div YieldTTM4.97%Amplitude1.020Historical Low1.582Avg Price1Lot Size
Ikena Oncology Key Stats
Ikena Oncology Earnings Estimates
Revenue
EPS
EBIT
Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement
Currency: USD
Actual
Estimate
Unlock Free Earnings Estimates
Open Account
Ikena Oncology Earnings Reports
Read more
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Analysis
Price Target
No Data